文献速递流行病学与生物统计真实世界研究与卫生经济

肥胖指标与肾小球滤过率下降风险:全球联盟个体参与者数据荟萃分析

Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium.
PubMed 文献 · BMJ · 2019-01-10

该个体参与者数据荟萃分析纳入40个国家1970至2017年的队列,评估体重指数、腰围和腰高比与肾小球滤过率(GFR)下降及全因死亡的关系。在一般人群队列中,较高的体重指数与GFR下降风险独立相关,且与死亡呈J形关联;腰围和腰高比与GFR下降的关联与体重指数相似,但未显示与死亡的低值风险关联。

要点

  • 体重指数30、35、40对比25的GFR下降风险比分别为1.18、1.69、2.02。
  • 调整合并症后关联减弱,但仍提示肥胖是GFR下降的独立危险因素。
  • 体重指数与死亡呈J形关联,最低风险在体重指数25。

核心结论

  • 在估算GFR正常或降低的个体中,升高的体重指数、腰围和腰高比是GFR下降和死亡的独立危险因素。

研究设计与样本

  • 个体参与者数据荟萃分析,纳入40个国家1970至2017年数据,包括39个一般人群队列(n=5 459 014)、6个高心血管风险队列(n=84 417)和18个慢性肾脏病队列(n=91 607)。

主要发现

  • 一般人群队列平均随访8年,246 607(5.6%)例发生GFR下降,18 118(0.4%)例终末期肾病事件,782 329(14.7%)例死亡。
  • 调整年龄、性别、种族和当前吸烟后,体重指数30、35、40对比25的GFR下降风险比分别为1.18(95%CI 1.09-1.27)、1.69(1.51-1.89)、2.02(1.80-2.27)。
  • 进一步调整合并症后风险比分别为1.03(0.95-1.11)、1.28(1.14-1.44)、1.46(1.28-1.67)。
  • 体重指数与死亡呈J形关联,最低风险在体重指数25;高心血管风险和慢性肾脏病队列中体重指数与GFR下降关联较弱,死亡最低风险在体重指数25-30。
  • 所有队列中腰围和腰高比与GFR下降的关联与体重指数相似,但死亡风险未显示与低腰围或低腰高比相关。

临床怎么用

  • 临床中可将体重指数、腰围和腰高比作为评估GFR下降和死亡风险的独立指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the associations between adiposity measures (body mass index, waist circumference, and waist-to-height ratio) with decline in glomerular filtration rate (GFR) and with all cause mortality. DESIGN: Individual participant data meta-analysis. SETTING: Cohorts from 40 countries with data collected between 1970 and 2017. PARTICIPANTS: Adults in 39 general population cohorts (n=5 459 014), of which 21 (n=594 496) had data on waist circumference; six cohorts with high cardiovascular risk (n=84 417); and 18 cohorts with chronic kidney disease (n=91 607). MAIN OUTCOME MEASURES: GFR decline (estimated GFR decline ≥40%, initiation of kidney replacement therapy or estimated GFR <10 mL/min/1.73 m2) and all cause mortality. RESULTS: Over a mean follow-up of eight years, 246 607 (5.6%) individuals in the general population cohorts had GFR decline (18 118 (0.4%) end stage kidney disease events) and 782 329 (14.7%) died. Adjusting for age, sex, race, and current smoking, the hazard ratios for GFR decline comparing body mass indices 30, 35, and 40 with body mass index 25 were 1.18 (95% confidence interval 1.09 to 1.27), 1.69 (1.51 to 1.89), and 2.02 (1.80 to 2.27), respectively. Results were similar in all subgroups of estimated GFR. Associations weakened after adjustment for additional comorbidities, with respective hazard ratios of 1.03 (0.95 to 1.11), 1.28 (1.14 to 1.44), and 1.46 (1.28 to 1.67). The association between body mass index and death was J shaped, with the lowest risk at body mass index of 25. In the cohorts with high cardiovascular risk and chronic kidney disease (mean follow-up of six and four years, respectively), risk associations between higher body mass index and GFR decline were weaker than in the general population, and the association between body mass index and death was also J shaped, with the lowest risk between body mass index 25 and 30. In all cohort types, associations between higher waist circumference and higher waist-to-height ratio with GFR decline were similar to that of body mass index; however, increased risk of death was not associated with lower waist circumference or waist-to-height ratio, as was seen with body mass index. CONCLUSIONS: Elevated body mass index, waist circumference, and waist-to-height ratio are independent risk factors for GFR decline and death in individuals who have normal or reduced levels of estimated GFR.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Chang AR, Grams ME, Ballew SH, et al. Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium. BMJ. 2019. PMID: 30630856. doi:10.1136/bmj.k5301

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。